Does sex or ethnicity impact anti-tumour necrosis factor agent use in rheumatoid arthritis?

Dennison, Elaine M; Jameson, Karen A; Marks, Jonathan; Watson, Kath; Hyrich, Kimme; Symmons, Deborah; Cooper, Cyrus

Dennison, Elaine M; Jameson, Karen A; Marks, Jonathan; Watson, Kath; Hyrich, Kimme; Symmons, Deborah; Cooper, Cyrus.

Afiliação

Dennison EM; MRC Lifecourse Epidemiology Unit.
Jameson KA; MRC Lifecourse Epidemiology Unit.
Marks J; Rheumatology Research Unit, University Hospitals Trust Southampton, Southampton.
Watson K; Arthritis Research UK Centre for Epidemiology, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Manchester University.
Hyrich K; Arthritis Research UK Centre for Epidemiology, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Manchester University.
Symmons D; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester.
Cooper C; Arthritis Research UK Centre for Epidemiology, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Manchester University.

Rheumatology (Oxford) ; 56(4): 663-665, 2017 04 01.

Article em En | MEDLINE | ID: mdl-28039417

Assuntos

Artrite Reumatoide; Fator de Necrose Tumoral alfa; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Fator de Necrose Tumoral alfa Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google